Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/29/2025 1:23:52 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1851
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
misiu143
07/30/2025 3:54:40 PM
It is not always easy , her doctor in a
(8)
ohm20
07/30/2025 3:48:55 PM
Dr Jay do not give RTT or
(11)
misiu143
07/30/2025 3:34:38 PM
Not always that easy to get IRB. Friend
(5)
sean007
07/30/2025 3:29:10 PM
The FDA approves over 99% of ALL
(12)
misiu143
07/30/2025 2:00:30 PM
Dr Jay do not give RTT or
(16)
NOMOD
07/30/2025 9:10:47 AM
Youre very welcome. Youre doing
(7)
cardamine
07/30/2025 1:30:00 AM
Thank you for writing all this out--it
(3)
NOMOD
07/30/2025 1:08:21 AM
I cant PM, so feel free to email me
(20)
cardamine
07/30/2025 12:50:56 AM
Quick Question re right to
(5)
sjacobs26
07/29/2025 4:37:59 PM
Just doing a quick comparisonCELC
(21)
cardamine
07/29/2025 3:23:29 PM
still as of yesterday, only approx 12
MidnightRider
07/29/2025 3:17:38 PM
From Reddit yesterday : r/Livimmune
(8)
Katangolo
07/29/2025 11:45:29 AM
Yes, mitochondrial dysfunction, Golgi
(2)
Katangolo
07/29/2025 11:44:14 AM
Amen. Youre dialed
(4)
Katangolo
07/29/2025 11:42:55 AM
Crp, iL-6, pd1 anything involved in
(8)
craigakess
07/29/2025 10:27:19 AM
I think you might mean 1.75 billion
(2)
MIM-104
07/29/2025 7:20:17 AM
You can read this in detail via this
(3)
docj
07/29/2025 7:11:27 AM
1,750 million authorized shares of
(2)
ohm20
07/29/2025 1:31:17 AM
IHUB is currently under federal watch
(16)
ohm20
07/29/2025 1:22:34 AM
There is one obvious bio-marker, or end
(20)
Figgs
07/28/2025 10:59:35 PM
Took long weekend to Canada. Nice
(2)
My69z
07/28/2025 10:43:02 PM
Deals for Phase 1 have brought $1b+.
(10)
JmcII
07/28/2025 10:19:04 PM
Does anyone know our total shares
sunray3
07/28/2025 7:32:47 PM
I'm sure you're right, there are going
Mr3Putt
07/28/2025 7:25:01 PM
2025-07-24 * Study Status * Arms and
(1)
Evil Rabbit
07/28/2025 7:16:25 PM
Clinictrials.gov is always late to be
(2)
Buddyboy20
07/28/2025 6:52:03 PM
Two study locations?
(1)
Mr3Putt
07/28/2025 6:40:22 PM
updates posted to CRC trial:
(7)
sherlock57
07/28/2025 4:46:46 PM
"Since we are doing a clinical trial,
(12)
sunray3
07/28/2025 12:02:02 PM
If so (not doubting you) then not
(8)
Buddyboy20
07/28/2025 11:25:09 AM
I can almost guarantee that his
(2)
sunray3
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's
(7)
Buddyboy20
07/28/2025 10:00:14 AM
It has been over one year that Dr Chan
(22)
Mr3Putt
07/28/2025 9:48:14 AM
Your question is answered precisely
(2)
SaltyMutt
07/28/2025 7:51:21 AM
Does this one fly soon?
(1)
bbqbbq
07/27/2025 10:12:45 PM
Garry Nolan is a prominent immunologist
(4)
My69z
07/27/2025 8:33:43 PM
Reason for S3's is being overlooked ---
(5)
sean007
07/27/2025 6:59:58 PM
You can believe with Tanya at the
(10)
USS JOHNSTON
07/27/2025 5:09:10 PM
Thanks, 3Putt, that discussion on
(7)
ohm20
07/27/2025 5:03:55 PM
Upwithstock to the rescue: As I said
(13)
sean007
07/27/2025 3:47:06 PM
"The Shelf offering"...shows We have a
(5)
Mr3Putt
07/27/2025 3:21:58 PM
Upwithstock to the rescue:
(13)
USS JOHNSTON
07/27/2025 2:54:06 PM
I'd like to hear from business-savvy
(1)
sean007
07/27/2025 2:41:17 PM
I am neither a monitor or a
(1)
biloxiblues
07/27/2025 1:17:33 PM
Thank you!
Evil Rabbit
07/27/2025 11:09:09 AM
Based on the correction, I deleted the
(3)
biloxiblues
07/27/2025 11:05:41 AM
Sean007 My source is incorrect about
(5)
Katangolo
07/27/2025 12:41:42 AM
Love it! Thanks, Brent and keep it
(1)
brentie
07/26/2025 11:57:39 PM
Not much to this article but I like
(3)
Katangolo
07/26/2025 10:56:08 PM
OK, now were talking. Brentie thanks
(2)
Newer
Older
Recent Articles
Electrolux Group Reports Positive Growth in Q3 2025 Results
Flow Traders Reports 3Q 2025 Results with Insights
Key Advantages of Cross-Straits Development for Unity
Electrolux Group Reports Strong Q3 Performance in 2025
Aker Horizons ASA Unveils Key Financials for Q3 2025
Electrolux Group Reports Strong Q3 Performance and Future Plans
Hikvision Launches Innovative AI Solutions to Support SMBs Growth
Revolutionizing AI Podcasts: The Soul App's New Voice Model
General Motors' Workforce Reductions and EV Market Challenges
Nobu Hospitality Expands Global Presence with Luxury Residences
United Imaging Healthcare Sees Growth in Q3 2025 Revenue
ING Achieves Impressive Results with €1.787 Billion Profit
Clariant Reports Growth in Q3 2025 EBITDA Margin Amid Challenges
Arcadis Q3 2025 Growth and Margin Expansion Overview
dsm-firmenich Delivers Promising Q3 2025 Update Insights
Pluxee Celebrates Strong Financial Performance for Fiscal 2025
Hansa Biopharma's Major Milestones and Financial Insights
Hansa Biopharma's Q3 Success and Future Growth Plans
Hansa Biopharma Shows Positive Progress with Imlifidase Trials
ING's Successful Share Buyback and New €1.6 Billion Plan
argenx Achieves Significant Milestones in Q3 2025
ING's Major Buyback and New Shareholder Distribution Plan
Jim Cramer Advocates Sharing Nvidia's Advanced Chips with China
Exploring the Expanding Horizons of Sustainable Materials Growth
The Future of Main Landing Gears Market and Industry Insights
Idorsia Reports Impressive Growth in QUVIVIQ Sales and Financials
argenx Excels with Strong Third Quarter Performance and Plans
Scatec Updates on Third Quarter Performance and Future Plans
PixVerse Partners with UNU Network to Promote AI for Good
United Imaging Healthcare's Revenue Growth Spikes in Q3 2025
Roche's Strategic Acquisition of 89bio: Making Waves in Biopharma
Nobu Hospitality Launches Exquisite Residences and Dining in Kuwait
Pluxee Announces Impressive Fiscal 2025 Performance Highlights
Pulsar Helium's Jetstream #3 Well Reaches Major Milestone
Arcadis Reports Q3 2025 Growth With Expanding Margins
Ontex's Q3 Results Show Strong Progress Despite Market Challenges
dsm-firmenich Reports Encouraging Q3 2025 Performance Insights
Clariant Reports Growth in EBITDA Margin amidst Challenges
EfTEN Real Estate Fund's Positive Growth Trajectory Unveiled
Telenor's Nordic Security Report Highlights Urgent Cyber Threats
TGS ASA Announces Ex-Dividend Trading at NOK 1.56 Today
Crédit Agricole S.A. Reports Strong Q3 and 9M 2025 Earnings
ING Reports Impressive €1.787 Billion Net Income for 2025 Q3
AI Computing Power: A Sustainable Solution for Retirement
Innovative Sugar Reduction Solutions Unveiled by Samyang Corp
Societe Generale Shows Impressive Financial Growth in Q3 2025
FMC Corporation Faces Significant Stock Decline After Earnings Report
Piramal Pharma Solutions Forms New Alliance with IntoCell
Piramal Pharma and IntoCell Collaborate for Advanced Bioconjugates
AI Computing Power: A Solution for America’s Retirement Dilemma